T
|
ANNUAL REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
£
|
TRANSITION REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
Delaware
|
06-1393453
|
|
(State
or other jurisdiction of incorporation or organization
|
(I.R.S. Employer
Identification
No.)
|
Title
of each class
|
Name
of each exchange on which registered
|
|
Common
Stock, $0.01 par value
|
The
NASDAQ Stock Market LLC
|
PART
I
|
||||
1.
|
3
|
|||
1A.
|
14
|
|||
1B.
|
19
|
|||
2.
|
19
|
|||
3.
|
19
|
|||
4.
|
19
|
|||
PART
II
|
||||
5.
|
19
|
|||
6.
|
22
|
|||
7.
|
23
|
|||
7A.
|
33
|
|||
8.
|
34
|
|||
9.
|
58
|
|||
9A.
|
58
|
|||
9B.
|
59
|
|||
PART
III
|
||||
10.
|
60
|
|||
11.
|
60
|
|||
12.
|
60
|
|||
13.
|
60
|
|||
14.
|
60
|
|||
PART
IV
|
||||
15.
|
61
|
|||
65
|
Item 1.
|
Business
|
|
·
|
Licensed
wire mesh filter technology to Headway Machine Co., Ltd. (Zhucheng City,
China), the largest commercial diesel engine exhaust company in China
which enables Headway to develop the wire mesh filter technology to
provide particulate matter emission reduction solutions to China-based
truck manufacturers.
|
|
·
|
Received
approval for the inclusion of our Purifier e4 retrofit technology in the
Scottish Government Emissions Reduction Register
program.
|
|
·
|
Executed
a worldwide, non-exclusive license agreement with Hilite International,
Inc., a leading supplier of automotive powertrain components headquartered
in Cleveland, Ohio that covers our patented Advanced Reagent Injector
System (ARIS) airless injection technology for selective catalytic
reduction (SCR) control of vehicle oxides of nitrogen emissions and rights
to our patented combination of the use of exhaust gas
recirculation (EGR) in conjunction with SCR for reducing fuel
consumption while meeting stringent emissions
standards.
|
|
·
|
Executed
non-exclusive worldwide license agreement with Eaton Corp. (Ohio US) that
covers our patented ARIS®
technologies for control of oxides of nitrogen using SCR emission control
and the combination of EGR with SCR technologies. Eaton will
use our technology for injection of hydrocarbon fuel in emissions
reduction applications, including Eaton's Aftertreatment
System. This technology can also be applied to regeneration of
diesel particulate filters and lean NOx traps in various global
applications.
|
|
·
|
Supplied
our Purifier particulate matter emission control technology as a retrofit
solution to commercial operators owning older vehicles to comply with
requirements for the London Low Emission Zone
(LEZ).
|
·
|
nitrogen
oxides (NOx);
|
·
|
particulate
matter (PM);
|
·
|
carbon
monoxide (CO);
|
·
|
hydrocarbon
(HC); and
|
·
|
carbon
dioxide (CO2).
|
|
·
|
Fuel-borne
catalysts;
|
|
·
|
Selective
catalytic reduction;
|
|
·
|
Catalyzed
wire mesh diesel particulate
filters;
|
|
·
|
Biofuels;
and
|
|
·
|
Emission
control systems.
|
|
·
|
The
cost effective means of controlling the principal emissions from diesel
engines (nitrogen oxides, particulate matter, carbon monoxide and
hydrocarbon).
|
|
·
|
Reduction
of carbon dioxide and other greenhouse gas emissions by enhancing
combustion efficiency and by enabling long-term reliable performance of
emission control systems.
|
|
·
|
Effective
utilization of strategic catalytic materials such as platinum enables
reduced emission control system costs, recycling strategies and low
nitrogen dioxide emission levels.
|
|
·
|
Low
cost, reliable and durable diesel particulate filter performance through
catalyzed wire mesh filter systems in retrofit
applications.
|
(in
thousands)
|
|||||||||||||||||||||||||
For the years ended December
31,
|
|||||||||||||||||||||||||
|
2008
|
2007
|
2006
|
||||||||||||||||||||||
|
|||||||||||||||||||||||||
Product
sales
|
$ | 7,024 | 94.0% | $ | 1,466 | 29.8% | $ | 860 | 76.6% | ||||||||||||||||
License
and royalty revenue
|
451 | 6.0% | 3,459 | 70.2% | 74 | 6.6% | |||||||||||||||||||
Consulting
and other
|
|
|
|
|
189 | 16.8% | |||||||||||||||||||
Total
|
$ | 7,475 | 100.0% | $ | 4,925 | 100.0% | $ | 1,123 | 100.0% |
Item 1A.
|
Risk
Factors
|
|
·
|
Actions
taken by regulatory bodies relating to the verification, registration or
health effects of our products.
|
|
·
|
The
extent to which our Platinum Plus fuel-borne catalyst and ARIS nitrogen
oxides reduction products obtain market
acceptance.
|
|
·
|
The
timing and size of customer
purchases.
|
|
·
|
Customer
concerns about the stability of our business which could cause them to
seek alternatives to our solutions and
products.
|
|
·
|
Increases
in raw material costs, especially
platinum.
|
Item 1B.
|
Unresolved
Staff Comments
|
Item 2.
|
Properties
|
Item 3.
|
Legal
Proceedings
|
Item 4.
|
Submission
of Matters to a Vote of Security
Holders
|
Item 5.
|
Market
for Registrant’s Common Equity, Related Stockholder Matters and Issuer
Purchases of Equity Securities
|
OTC
Bulletin Board or
|
AIM
of the
|
|||||||||||||||
NASDAQ
Capital Market
|
London
Stock Exchange
|
|||||||||||||||
High
|
Low
|
High
|
Low
|
|||||||||||||
(In
U.S. $)
|
(In
GBP)
|
|||||||||||||||
2007
|
||||||||||||||||
1st
Quarter
|
$ | 12.25 | $ | 9.00 | £ | 6.00 | £ | 4.25 | ||||||||
2nd
Quarter
|
$ | 17.00 | $ | 10.25 | £ | 7.75 | £ | 4.65 | ||||||||
3rd
Quarter
|
$ | 15.00 | $ | 11.00 | £ | 8.00 | £ | 5.50 | ||||||||
4th
Quarter
|
$ | 30.00 | $ | 12.50 | £ | 13.24 | £ | 6.10 | ||||||||
2008
|
||||||||||||||||
1st
Quarter
|
$ | 24.85 | $ | 8.74 | £ | 11.50 | £ | 5.00 | ||||||||
2nd
Quarter
|
$ | 15.98 | $ | 10.50 | £ | 7.05 | £ | 5.00 | ||||||||
3rd
Quarter
|
$ | 12.25 | $ | 3.00 | £ | 6.23 | £ | 2.98 | ||||||||
4th
Quarter
|
$ | 4.79 | $ | 1.54 | £ | 3.00 | £ | 1.10 |
Plan
Category
|
Number of Shares to be
Issued Upon Exercise of
Outstanding Options, Warrants and
Rights
|
Weighted Average
Exercise Price of
Outstanding Options, Warrants and
Rights
|
Number of Shares Remaining Available for Future
Issuance
|
|||||||||
Options:
|
||||||||||||
Equity
compensation plans approved by security holders
|
972,5781 | $ | 10.19 | 451,6251 | ||||||||
Equity
compensation plans not approved by security holders
|
— | — | — | |||||||||
Total
Options
|
972,578 | $ | 10.19 | 451,625 | ||||||||
Warrants:
|
||||||||||||
Equity
compensation plans approved by shareholders
|
— | — | — | |||||||||
Equity
compensation plans not approved by shareholders
|
424,992 | $ | 11.35 | — | ||||||||
Total
Warrants
|
424,992 | $ | 11.35 | — |
1
|
Represents
awards issued under the Incentive Plan. The maximum number
of awards allowed under the Incentive Plan is 17.5% of our issued and
outstanding common stock less the outstanding options, and is subject to a
sufficient number of shares of authorized
capital.
|
12/31/03
|
12/31/04
|
12/31/05
|
12/31/06
|
12/31/07
|
12/31/08
|
|||||||||||||||||||
Clean Diesel Technologies,
Inc.
|
$ | 100 | $ | 60 | $ | 35 | $ | 63 | $ | 161 | $ | 18 | ||||||||||||
Russell 2000 Index
|
100 | 117 | 121 | 141 | 138 | 90 | ||||||||||||||||||
NASDAQ Composite Index
|
100 | 109 | 111 | 122 | 132 | 64 |
Item 6.
|
Selected
Financial Data
|
For the years ended December
31,
|
||||||||||||||||||||
2008
|
2007
|
2006
|
2005
|
2004
|
||||||||||||||||
(in
thousands, except per share amounts)
|
||||||||||||||||||||
STATEMENTS
OF OPERATIONS DATA
|
||||||||||||||||||||
Revenue:
|
||||||||||||||||||||
Product
sales
|
$ | 7,024 | $ | 1,466 | $ | 860 | $ | 760 | $ | 659 | ||||||||||
License
and royalty revenue
|
451 | 3,459 | 74 | 47 | 54 | |||||||||||||||
Consulting
and other
|
─
|
─
|
189 | 5 | 9 | |||||||||||||||
Total
revenue
|
7,475 | 4,925 | 1,123 | 812 | 722 | |||||||||||||||
Operating
costs and expenses:
|
||||||||||||||||||||
Cost
of total revenue
|
5,717 | 1,126 | 658 | 471 | 455 | |||||||||||||||
Selling,
general and administrative
|
9,992 | 8,041 | 5,278 | 4,963 | 3,962 | |||||||||||||||
Research
and development
|
430 | 428 | 510 | 439 | 506 | |||||||||||||||
Patent
amortization and other expense
|
227 | 364 | 235 | 170 | 90 | |||||||||||||||
Loss
from operations
|
(8,891 | ) | (5,034 | ) | (5,558 | ) | (5,231 | ) | (4,291 | ) | ||||||||||
Foreign
currency exchange (loss) gain
|
(845 | ) | (11 | ) | 104 | (221 | ) | 101 | ||||||||||||
Interest
income
|
602 | 509 | 58 | 26 | 47 | |||||||||||||||
Other
income (expense), net
|
(239 | ) | 1 | 12 |
─
|
─
|
||||||||||||||
Net
loss
|
$ | (9,373 | ) | $ | (4,535 | ) | $ | (5,384 | ) | $ | (5,426 | ) | $ | (4,143 | ) | |||||
Basic
and diluted loss per common share
|
$ | (1.15 | ) | $ | (0.66 | ) | $ | (1.03 | ) | $ | (1.48 | ) | $ | (1.29 | ) | |||||
Basic
and diluted weighted-average shares
outstanding
|
8,138 | 6,886 | 5,212 | 3,678 | 3,214 | |||||||||||||||
As of December 31,
|
||||||||||||||||||||
2008
|
2007
|
2006
|
2005
|
2004
|
||||||||||||||||
(in
thousands)
|
||||||||||||||||||||
BALANCE
SHEET DATA
|
||||||||||||||||||||
Current
assets
|
$ | 12,219 | $ | 11,871 | $ | 8,287 | $ | 5,505 | $ | 4,868 | ||||||||||
Total
assets
|
18,747 | 24,663 | 9,018 | 6,274 | 5,513 | |||||||||||||||
Current
liabilities
|
4,056 | 1,663 | 1,070 | 496 | 391 | |||||||||||||||
Long-term
liabilities
|
─
|
─
|
─
|
─
|
─
|
|||||||||||||||
Working
capital
|
8,163 | 10,208 | 7,217 | 5,009 | 4,477 | |||||||||||||||
Stockholders’
equity
|
14,691 | 23,000 | 7,948 | 5,778 | 5,122 |
Item 7.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
(in
thousands)
|
||||||||||||||||||||||||
For the years ended December
31,
|
||||||||||||||||||||||||
2008
|
2007
|
2006
|
||||||||||||||||||||||
Product
sales
|
$ | 7,024 | 94.0% | $ | 1,466 | 29.8% | $ | 860 | 76.6% | |||||||||||||||
License
and royalty revenue
|
451 | 6.0% | 3,459 | 70.2% | 74 | 6.6% | ||||||||||||||||||
Consulting
and other
|
|
|
|
|
189 | 16.8% | ||||||||||||||||||
Total
|
$ | 7,475 | 100.0% | $ | 4,925 | 100.0% | $ | 1,123 | 100.0% |
(in
thousands)
|
||||||||
Years ended December 31,
|
||||||||
2008
|
2007
|
|||||||
Non-cash
stock-based compensation
|
$ | 1,204 | $ | 1,966 | ||||
Compensation
and benefits
|
4,386 | 2,997 | ||||||
Total
compensation and benefits
|
$ | 5,590 | $ | 4,963 | ||||
Professional
services
|
1,683 | * | 1,487 | * | ||||
Travel
|
712 | 622 | ||||||
Occupancy,
property and business taxes, supplies, postage and
delivery
|
859 | 511 | ||||||
Sales
and marketing expenses
|
400 | 341 | ||||||
Bad
debt expense
|
629 | 28 | ||||||
Depreciation
and all other
|
119 | 89 | ||||||
Total
|
$ | 9,992 | $ | 8,041 |
(in
thousands)
|
||||||||
Years ended December 31,
|
||||||||
2007
|
2006
|
|||||||
Non-cash
stock-based compensation
|
$ | 1,966 | $ | 304 | ||||
Severance
|
|
357 | ||||||
Compensation
and benefits
|
2,997 | 2,400 | ||||||
Total
compensation and benefits
|
$ | 4,963 | $ | 3,061 | ||||
Professional
services
|
1,487 | * | 792 | |||||
Travel
|
622 | 538 | ||||||
Occupancy
|
511 | 406 | ||||||
Sales
and marketing expenses
|
341 | 279 | ||||||
Bad
debts
|
28 | 33 | ||||||
Depreciation
and all other
|
89 | 169 | ||||||
Total
|
$ | 8,041 | $ | 5,278 |
(in
thousands)
|
||||||||||||||||||||
2
to 3
|
4
to 5
|
Over
5
|
||||||||||||||||||
Total
|
1 Year
|
Years
|
Years
|
Years
|
||||||||||||||||
Operating
Leases
|
$ | 1,215 | $ | 201 | $ | 361 | $ | 349 | $ | 304 | ||||||||||
Item 7A.
|
Quantitative
and Qualitative Disclosures about Market
Risk
|
Item 8.
|
Consolidated
Financial Statements and Supplementary
Data
|
December 31,
|
||||||||
2008
|
2007
|
|||||||
Assets
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 3,976 | $ | 1,517 | ||||
Accounts
receivable, net of allowance of $359 and $49, respectively
|
637 | 1,927 | ||||||
Investments
|
6,413 | 7,100 | ||||||
Inventories,
net
|
974 | 1,093 | ||||||
Other
current assets
|
219 | 234 | ||||||
Total
current assets
|
12,219 | 11,871 | ||||||
Investments
|
5,127 | 11,725 | ||||||
Patents,
net
|
1,027 | 817 | ||||||
Fixed
assets, net of accumulated depreciation of $505 and $421,
respectively
|
296 | 175 | ||||||
Other
assets
|
78 | 75 | ||||||
Total
assets
|
$ | 18,747 | $ | 24,663 | ||||
Liabilities
and Stockholders’ Equity
|
||||||||
Current
liabilities:
|
||||||||
Accounts
payable
|
$ | 501 | $ | 757 | ||||
Accrued
expenses
|
534 | 850 | ||||||
Short-term
debt
|
3,013 |
─
|
||||||
Customer
deposits
|
8 | 56 | ||||||
Total
current liabilities
|
4,056 | 1,663 | ||||||
Commitments
(Note 10)
|
||||||||
Stockholders’
equity:
|
||||||||
Preferred
stock, par value $0.01 per share: authorized 100,000; no shares issued and
outstanding
|
─
|
─
|
||||||
Common
stock, par value $0.01 per share: authorized 12,000,000; issued and
outstanding 8,138,304 and 8,124,056 shares, respectively
|
81 | 81 | ||||||
Additional
paid-in capital
|
73,901 | 72,447 | ||||||
Accumulated
other comprehensive loss
|
(406 | ) | (16 | ) | ||||
Accumulated
deficit
|
(58,885 | ) | (49,512 | ) | ||||
Total
stockholders’ equity
|
14,691 | 23,000 | ||||||
Total
liabilities and stockholders’ equity
|
$ | 18,747 | $ | 24,663 | ||||
The
accompanying notes are an integral part of the consolidated financial
statements.
|
For the years ended December
31,
|
||||||||||||
Revenue:
|
2008
|
2007
|
2006
|
|||||||||
Product
sales
|
$ | 7,024 | $ | 1,466 | $ | 860 | ||||||
Technology
licensing fees and royalties
|
451 | 3,459 | 74 | |||||||||
Consulting
and other
|
─
|
─
|
189 | |||||||||
Total
revenue
|
7,475 | 4,925 | 1,123 | |||||||||
Costs
and expenses:
|
||||||||||||
Cost
of product sales
|
5,717 | 1,126 | 612 | |||||||||
Cost
of licensing fees and royalties
|
─
|
─
|
─
|
|||||||||
Cost
of consulting and other revenue
|
─
|
─
|
46 | |||||||||
Selling,
general and administrative
|
9,992 | 8,041 | 5,278 | |||||||||
Research
and development
|
430 | 428 | 510 | |||||||||
Patent
amortization and other expense
|
227 | 364 | 235 | |||||||||
Operating
costs and expenses
|
16,366 | 9,959 | 6,681 | |||||||||
|
||||||||||||
Loss
from operations
|
(8,891 | ) | (5,034 | ) | (5,558 | ) | ||||||
Other
income (expense):
|
||||||||||||
Foreign
currency exchange (loss) gain
|
(845 | ) | (11 | ) | 104 | |||||||
Interest
income
|
602 | 509 | 58 | |||||||||
Other
|
(239 | ) | 1 | 12 | ||||||||
Net
loss
|
$ | (9,373 | ) | $ | (4,535 | ) | $ | (5,384 | ) | |||
Basic
and diluted loss per common share
|
$ | (1.15 | ) | $ | (0.66 | ) | $ | (1.03 | ) | |||
Basic
and diluted weighted-average number of common
shares outstanding
|
8,138 | 6,886 | 5,212 | |||||||||
Consolidated
Statements of Comprehensive Loss
|
||||||||||||
(in
thousands)
|
||||||||||||
For the years ended December
31,
|
||||||||||||
2008
|
2007
|
2006
|
||||||||||
Net
loss
|
$ | (9,373 | ) | $ | (4,535 | ) | $ | (5,384 | ) | |||
Other
comprehensive income (loss):
|
||||||||||||
Foreign
currency translation adjustment
|
(390 | ) | (20 | ) | 4 | |||||||
Comprehensive
loss
|
$ | (9,763 | ) | $ | (4,555 | ) | $ | (5,380 | ) | |||
The
accompanying notes are an integral part of the consolidated financial
statements.
|
Additional
Paid-in
Capital
|
Accumulated
Other
Comprehensive
Income (Loss)
|
Accumulated
Deficit
|
Total
Stockholders’
Equity
|
|||||||||||||||||||||||||||||
Common
Stock
|
||||||||||||||||||||||||||||||||
Common Stock
|
To be Issued
|
|||||||||||||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
|||||||||||||||||||||||||||||
Balance
at December 31, 2005
|
5,073 | $ | 51 | 141 | $ | 1 | $ | 45,319 |
$ ─
|
$ | (39,593 | ) | $ | 5,778 | ||||||||||||||||||
Net
loss
|
─
|
─
|
─
|
─
|
─
|
─
|
(5,384 | ) | (5,384 | ) | ||||||||||||||||||||||
Options
exercised
|
3 |
─
|
─
|
─
|
14 |
─
|
─
|
14 | ||||||||||||||||||||||||
Compensation
expense for stock
options
|
─
|
─
|
─
|
─
|
304 |
─
|
─
|
304 | ||||||||||||||||||||||||
Issuance
of common stock
|
876 | 9 | (141 | ) | (1 | ) | 4,718 |
─
|
─
|
4,726 | ||||||||||||||||||||||
Common
stock subscribed and to
be issued
|
─
|
─
|
668 | 7 | 4,306 |
─
|
─
|
4,313 | ||||||||||||||||||||||||
Subscriptions
receivable, net (unpaid
as of March 23, 2007)
|
─
|
─
|
─
|
─
|
(1,901 | ) |
─
|
─
|
(1,901 | ) | ||||||||||||||||||||||
Foreign
currency translation
|
─
|
─
|
─
|
─
|
─
|
4 |
─
|
4 | ||||||||||||||||||||||||
Payment
of directors’ fees in common
stock
|
12 |
─
|
─
|
─
|
94 |
─
|
─
|
94 | ||||||||||||||||||||||||
Balance
at December 31, 2006
|
5,964 | $ | 60 | 668 | $ | 7 | $ | 52,854 | $ | 4 | $ | (44,977 | ) | $ | 7,948 | |||||||||||||||||
Net
loss
|
─
|
─
|
─
|
─
|
─
|
─
|
(4,535 | ) | (4,535 | ) | ||||||||||||||||||||||
Warrants
exercised
|
1,400 | 14 |
─
|
─
|
15,159 |
─
|
─
|
15,173 | ||||||||||||||||||||||||
Options
exercised
|
72 |
─
|
─
|
─
|
353 |
─
|
─
|
353 | ||||||||||||||||||||||||
Compensation
expense for stock
options
|
─
|
─
|
─
|
─
|
2,208 |
─
|
─
|
2,208 | ||||||||||||||||||||||||
Issuance
of common stock
|
668 | 7 | (668 | ) | (7 | ) | 1,901 |
─
|
─
|
1,901 | ||||||||||||||||||||||
Foreign
currency translation
|
─
|
─
|
─
|
─
|
─
|
(20 | ) |
─
|
(20 | ) | ||||||||||||||||||||||
Expenses
of registration and reverse
split
|
─
|
─
|
─
|
─
|
(168 | ) |
─
|
─
|
(168 | ) | ||||||||||||||||||||||
Payment
of directors’ fees in common
stock
|
20 |
─
|
─
|
─
|
140 |
─
|
─
|
140 | ||||||||||||||||||||||||
Balance
at December 31, 2007
|
8,124 | $ | 81 |
─
|
$
|
─
|
$ | 72,447 | $ | (16 | ) | $ | (49,512 | ) | $ | 23,000 | ||||||||||||||||
Net
loss
|
─
|
─
|
─
|
─
|
─
|
─
|
(9,373 | ) | (9,373 | ) | ||||||||||||||||||||||
Options
exercised
|
14 |
─
|
─
|
─
|
24 |
─
|
─
|
24 | ||||||||||||||||||||||||
Compensation
expense for stock
options
|
─
|
─
|
─
|
─
|
1,444 |
─
|
─
|
1,444 | ||||||||||||||||||||||||
Expenses
of registration
|
─
|
─
|
─
|
─
|
(14 | ) |
─
|
─
|
(14 | ) | ||||||||||||||||||||||
Foreign
currency translation
|
─
|
─
|
─
|
─
|
─
|
(390 | ) |
─
|
(390 | ) | ||||||||||||||||||||||
Balance
at December 31, 2008
|
8,138 | $ | 81 |
─
|
$
|
─
|
$ | 73,901 | $ | (406 | ) | $ | (58,885 | ) | $ | 14,691 | ||||||||||||||||
The
accompanying notes are an integral part of the consolidated financial
statements.
|
For the years ended December
31,
|
||||||||||||
2008
|
2007
|
2006
|
||||||||||
Operating
activities
|
||||||||||||
Net
loss
|
$ | (9,373 | ) | $ | (4,535 | ) | $ | (5,384 | ) | |||
Adjustments
to reconcile net loss to cash used in operating
activities:
|
||||||||||||
Depreciation
and amortization
|
142 | 112 | 138 | |||||||||
Provision
for inventory
|
─
|
22 | 27 | |||||||||
Provision
for doubtful accounts, net
|
629 | 28 | 23 | |||||||||
Compensation
expense for stock options and warrants
|
1,444 | 2,208 | 304 | |||||||||
Loss
on disposition/abandonment of fixed assets/patents
|
38 | 58 | 23 | |||||||||
Loss
on investments, net
|
185 |
─
|
─
|
|||||||||
Changes
in operating assets and liabilities:
|
||||||||||||
Accounts
receivable
|
661 | (1,855 | ) | 2 | ||||||||
Inventories
|
119 | (750 | ) | (107 | ) | |||||||
Other
current assets and other assets
|
12 | (177 | ) | (12 | ) | |||||||
Accounts
payable and accrued expenses
|
(572 | ) | 677 | 678 | ||||||||
Other
liabilities
|
(48 | ) | 56 | (9 | ) | |||||||
Net
cash used for operating activities
|
(6,763 | ) | (4,156 | ) | (4,317 | ) | ||||||
Investing
activities
|
||||||||||||
Sale
(purchase) of investments, net
|
7,100 | (18,825 | ) |
─
|
||||||||
Patent
costs
|
(299 | ) | (313 | ) | (94 | ) | ||||||
Purchase
of fixed assets
|
(212 | ) | (154 | ) | (20 | ) | ||||||
Net
cash provided by (used for) investing activities
|
6,589 | (19,292 | ) | (114 | ) | |||||||
Financing
activities
|
||||||||||||
Proceeds
from short-term debt
|
3,013 |
─
|
─
|
|||||||||
Proceeds
from issuance of common stock, net
|
─
|
4,313 | 5,214 | |||||||||
Proceeds
from exercise of warrants
|
─
|
15,173 |
─
|
|||||||||
Proceeds
from exercise of stock options
|
24 | 353 | 14 | |||||||||
Stockholder-related
charges
|
(14 | ) | (168 | ) |
─
|
|||||||
Net
cash provided by financing activities
|
3,023 | 19,671 | 5,228 | |||||||||
Effect
of exchange rate changes on cash
|
(390 | ) | (20 | ) | 4 | |||||||
Net
increase (decrease) in cash and cash equivalents
|
$ | 2,459 | $ | (3,797 | ) | $ | 801 | |||||
Cash
and cash equivalents at beginning of the year
|
1,517 | 5,314 | 4,513 | |||||||||
Cash
and cash equivalents at end of the year
|
$ | 3,976 | $ | 1,517 | $ | 5,314 | ||||||
Supplemental
non-cash activities:
|
||||||||||||
Common
stock subscribed, net
|
$
|
─
|
$
|
─
|
$ | 4,313 | ||||||
Payment
of accrued directors’ fees in common stock
|
─
|
140 | 94 | |||||||||
The
accompanying notes are an integral part of the consolidated financial
statements.
|
|
·
|
Defines
fair value as the price that would be received to sell an asset or paid to
transfer a liability in an orderly transaction between market participants
at the measurement date;
|
|
·
|
Establishes
a three-level hierarchy (“valuation hierarchy”) for fair value
measurements;
|
|
·
|
Requires
consideration of the Company’s creditworthiness when valuing liabilities;
and
|
|
·
|
Expands
disclosures about instruments measured at fair
value.
|
|
·
|
Level
1 – inputs to the valuation methodology are quoted prices (unadjusted) for
identical assets or liabilities in active
markets.
|
|
·
|
Level
2 – inputs to the valuation methodology include quoted prices for similar
assets and liabilities in active markets, and inputs that are observable
for the asset or liability, either directly or indirectly, for
substantially the full term of the financial
instrument.
|
|
·
|
Level
3 – inputs to the valuation methodology are unobservable and significant
to the fair value measurement.
|
As
a percentage of consolidated revenue:
|
||||||||||||
Years ended December 31,
|
||||||||||||
2008
|
2007
|
2006
|
||||||||||
Customer
A
|
15.1 | % | * | * | ||||||||
Customer
B
|
* | 30.5 | % | * | ||||||||
Customer
C
|
* | 24.3 | % | * | ||||||||
Customer
D
|
* | 15.5 | % | * | ||||||||
Customer
E
|
* | * | 29 | % | ||||||||
Customer
F
|
* | * | 13 | % |
|
*
|
Represents less than 10% revenue
for that customer in the applicable year. There were no other
customers that represented 10% or more of revenue for the years
indicated.
|
(in
thousands)
|
||||||||||||
Years ended December 31,
|
||||||||||||
2008
|
2007
|
2006
|
||||||||||
Non-cash
stock-based compensation
|
$ | 1,204 | $ | 1,966 | $ | 304 | ||||||
Severance
|
|
|
357 | |||||||||
Compensation
and benefits
|
4,386 | 2,997 | 2,400 | |||||||||
Total
compensation and benefits
|
$ | 5,590 | $ | 4,963 | $ | 3,061 | ||||||
Professional
services
|
1,683 | * | 1,487 | * | 792 | |||||||
Travel
|
712 | 622 | 538 | |||||||||
Occupancy,
property and business taxes, supplies, postage and
delivery
|
859 | 511 | 406 | |||||||||
Sales
and marketing expenses
|
400 | 341 | 279 | |||||||||
Bad
debt expense
|
629 | 28 | 33 | |||||||||
Depreciation
and all other
|
119 | 89 | 169 | |||||||||
Total
|
$ | 9,992 | $ | 8,041 | $ | 5,278 |
(in
thousands)
|
||||||||
December 31,
|
||||||||
2008
|
2007
|
|||||||
Finished
Platinum Plus fuel-borne catalyst
|
$ | 144 | $ | 165 | ||||
Platinum
concentrate/metal
|
578 | 656 | ||||||
Hardware
|
268 | 260 | ||||||
Other
|
6 | 34 | ||||||
$ | 996 | $ | 1,115 | |||||
Less:
inventory reserves
|
(22 | ) | (22 | ) | ||||
Inventories,
net
|
$ | 974 | $ | 1,093 |
(in
thousands)
|
||||||||
December 31,
|
||||||||
2008
|
2007
|
|||||||
Patents
|
$ | 1,220 | $ | 975 | ||||
Less:
accumulated amortization
|
(193 | ) | (158 | ) | ||||
Patents,
net
|
$ | 1,027 | $ | 817 |
(in
thousands)
|
||||||||
December
31,
|
||||||||
2008
|
2007
|
|||||||
Auction
rate securities
|
$ | 10,235 | $ | 18,825 | ||||
Auction
rate securities right
|
1,305 |
─
|
||||||
Total
investments
|
$ | 11,540 | $ | 18,825 | ||||
Classified
as current assets
|
6,413 | 7,100 | ||||||
Classified
as non-current assets
|
$ | 5,127 | $ | 11,725 |
(in
thousands)
|
||||||||
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
|||||||
Fair
value, January 1, 2008
|
$ | 18,825 | $ | — | ||||
Purchases
|
— | — | ||||||
Sales
|
(7,100 | ) | — | |||||
Transfers
(out) in
|
(11,725 | ) | 11,725 | |||||
Unrealized
loss included in statement of operations
|
— | (185 | ) | |||||
Fair
value, December 31, 2008
|
$ | — | $ | 11,540 | ||||
Change
in unrealized loss
|
$ | ( 185 | ) |
(in
thousands)
|
||||||||
December 31,
|
||||||||
2008
|
2007
|
|||||||
Professional
fees
|
$ | 168 | $ | 264 | ||||
Accrued
compensation
|
234 | 254 | ||||||
Accrued
directors’ and technical advisory board fees
|
─
|
44 | ||||||
Accrual
for inventory received
|
─
|
106 | ||||||
Value
added taxes payable
|
9 | 98 | ||||||
Travel
and all other
|
123 | 84 | ||||||
Accrued
expenses
|
$ | 534 | $ | 850 |
Shares
subscribed in the 2006 private placement
|
667,999 | |||
Shares
issued upon exercise of Class A warrants
|
699,883 | |||
Shares
issued upon exercise of Class B warrants
|
699,990 | |||
Shares
issued upon exercise of options
|
72,178 | |||
Shares
issued for services
|
19,599 | |||
2,159,649 |
|
(i)
|
The
Company sold and the investors bought units of one share of common stock
and warrants (effectively, one-half of each of Class A and B warrants) to
buy one share of common stock for the consideration of $6.75 per
unit;
|
(ii)
|
The
investors represented that they were acquiring the shares, the warrants
and the shares of common stock underlying the warrants for their own
accounts as an investment, and undertook with respect to these securities
to comply with the transfer restrictions of Regulation S or Regulation D
under the Securities Act of 1933, as the case may
be;
|
(iii)
|
The
Company undertook to apply for the listing of its outstanding shares on
the American Stock Exchange or another recognized U.S. stock exchange at
such time as the Company should satisfy the applicable listing
requirements; and
|
(iv)
|
The
Company undertook to file a registration statement under the Securities
Act of 1933 covering the shares and the shares of common stock underlying
the warrants following completion of the audit of its financial statements
for the year 2006. The agreements did not contain a penalty
provision for the Company’s failure to file that registration
statement.
|
Years ended December 31,
|
||||||||||||
2008
|
2007
|
2006
|
||||||||||
Expected
term in years
|
8.84 | 8.75 | 8.64 | |||||||||
Risk-free
interest rate
|
2.46% | 2.38% | 4.56% | |||||||||
Expected
volatility
|
89.1% | 97.5% | 104.7% | |||||||||
Dividend
yield
|
0% | 0% | 0% |
2008
|
2007
|
2006
|
||||||||||||||||||||||
Shares
|
Weighted
Average
Exercise
Price
|
Shares
|
Weighted
Average
Exercise
Price
|
Shares
|
Weighted
Average
Exercise
Price
|
|||||||||||||||||||
Outstanding
at beginning of year
|
812,844 | $ | 11.72 | 648,087 | $ | 10.08 | 649,187 | $ | 10.31 | |||||||||||||||
Options
granted
|
202,500 | $ | 4.18 | 291,166 | $ | 14.57 | 21,000 | $ | 8.32 | |||||||||||||||
Options
exercised
|
(27,166 | ) | $ | 10.37 | (93,609 | ) | $ | 7.55 | (3,000 | ) | $ | 4.50 | ||||||||||||
Options
expired
|
(1,500 | ) | $ | 10.00 | (20,333 | ) | $ | 23.02 | (9,667 | ) | $ | 23.08 | ||||||||||||
Options
forfeited
|
(14,100 | ) | $ | 11.19 | (12,467 | ) | $ | 6.17 | (9,433 | ) | $ | 10.00 | ||||||||||||
Outstanding
at end of year
|
972,578 | $ | 10.19 | 812,844 | $ | 11.72 | 648,087 | $ | 10.08 | |||||||||||||||
Options
exercisable at year-end
|
780,744 | $ | 10.62 | 657,177 | $ | 11.21 | 597,931 | $ | 10.41 | |||||||||||||||
Options
available for grant at year-end
|
451,625 | 608,866 | 144,853 | |||||||||||||||||||||
Weighted-average
fair value of options
granted during the year
|
$ | 3.18 | $ | 11.65 | $ | 7.47 | ||||||||||||||||||
Aggregate
intrinsic value – options
exercised
|
$ | 288,414 | $ | 880,974 | $ | 3,000 | ||||||||||||||||||
Aggregate
intrinsic value – options
outstanding
|
$ | — | ||||||||||||||||||||||
Aggregate
intrinsic value – options
exercisable
|
$ | — |
Options Outstanding
|
Options Exercisable
|
|||||||||||||||||||||
Range of
Exercise Prices
|
Number
Outstanding
|
Weighted
Average
Remaining
Contractual
Life
(In Years)
|
Weighted
Average
Exercise
Price
|
Number
Exercisable
|
Weighted
Average
Exercise
Price
|
|||||||||||||||||
$2.705 | 174,500 | 9.98 | $ 2.71 | 80,500 | $ 2.71 | |||||||||||||||||
$3.60 – $7.875 | 119,767 | 5.49 | $ 5.63 | 114,767 | $ 5.57 | |||||||||||||||||
$8.25 – $9.10 | 199,910 | 7.23 | $ 8.78 | 161,244 | $ 8.73 | |||||||||||||||||
$9.20 – $10.125 | 128,200 | 4.81 | $ 9.65 | 128,200 | $ 9.65 | |||||||||||||||||
$12.50 – $16.50 | 184,700 | 3.35 | $ 14.28 | 178,867 | $ 14.28 | |||||||||||||||||
$16.99 – $19.125 | 165.501 | 8.98 | $ 18.97 | 117,167 | $ 19.05 | |||||||||||||||||
$2.705 – $19.125 | 972,578 | 6.75 | $ 10.19 | 780,744 | $ 10.62 |
2008
|
2007
|
2006
|
||||||||||||||||||||||
Shares
|
Weighted
Average
Exercise
Price
|
Shares
|
Weighted
Average
Exercise
Price
|
Shares
|
Weighted
Average
Exercise
Price
|
|||||||||||||||||||
Outstanding
at beginning of year
|
424,992 | $ | 11.35 | 1,557,424 | $ | 10.98 | 101,346 | $ | 8.84 | |||||||||||||||
Warrants
to be issued
|
─
|
$ ─
|
143,432 | $ | 14.09 | 1,466,400 | $ | 11.13 | ||||||||||||||||
Warrants
issued
|
─
|
$ ─
|
124,142 | $ | 11.67 |
─
|
$
|
─
|
||||||||||||||||
Warrants
exercised
|
─
|
$ ─
|
(1,399,873 | ) | $ | 11.25 |
─
|
$
|
─
|
|||||||||||||||
Warrants
expired / forfeited
|
─
|
$ ─
|
(133 | ) | $ | 7.71 | (10,322 | ) | $ | 10.00 | ||||||||||||||
Outstanding
and to be issued at
end of year
|
424,992 | $ | 11.35 | 424,992 | $ | 11.35 | 1,557,424 | $ | 10.98 | |||||||||||||||
Warrants
exercisable at year-end
|
424,992 | $ | 11.35 | 424,992 | $ | 11.35 | 1,557,424 | $ | 10.98 | |||||||||||||||
Aggregate
intrinsic value
|
$ ─
|
$ | 4,953,662 | $ | 102,325 |
Warrants Outstanding and
Exercisable
|
|||||||||||||
Range
of
Exercise Prices
|
Number
Outstanding
And
Exercisable
|
Weighted
Average
Remaining
Contractual
Life
(In Years)
|
Weighted
Average
Exercise
Price
|
||||||||||
$ 7.50 – $8.15 |
63,053
|
3.54
|
$ 7.97
|
||||||||||
$
8.44
|
140,542
|
|
3.00
|
$
8.44
|
|||||||||
$ 10.00
- $16.45
|
221,397
|
3.53
|
$
14.15
|
||||||||||
424,992
|
3.35
|
$
11.35
|
December 31,
|
||||||||
2008
|
2007
|
|||||||
Research
and development
|
$ | 1,789 | $ | 1,746 | ||||
Net
operating loss carryforwards
|
18,867 | 16,229 | ||||||
Reserves
|
140 |
|
||||||
Options
|
968 | 531 | ||||||
Deferred
tax assets
|
21,764 | 18,506 | ||||||
Less:
valuation allowance
|
(21,764 | ) | (18,506 | ) | ||||
Deferred
tax assets, net
|
$
|
|
$
|
|
Years ended December 31,
|
||||||||||||
2008
|
2007
|
2006
|
||||||||||
Federal
taxes (benefits) at statutory rates
|
(34% | ) | (34% | ) | (34% | ) | ||||||
State
taxes (benefits) rate
|
(5% | ) | (5% | ) | (5% | ) | ||||||
Change
in valuation allowance
|
39% | 39% | 39% | |||||||||
Income
taxes (benefits)
|
%
|
%
|
%
|
(in
thousands)
|
||||||||||||
Years ended December 31,
|
||||||||||||
2008
|
2007
|
2006
|
||||||||||
U.S.
|
$ | 905 | $ | 2,563 | $ | 684 | ||||||
Europe
|
6,405 | 2,255 | 117 | |||||||||
Asia
|
165 | 107 | 322 | |||||||||
Total
revenue
|
$ | 7,475 | $ | 4,925 | $ | 1,123 |
(in
thousands)
|
||||||||
December 31,
|
||||||||
2008
|
2007
|
|||||||
U.S.
|
$ | 17,214 | $ | 22,680 | ||||
Foreign
|
1,533 | 1,983 | ||||||
Total
assets
|
$ | 18,747 | $ | 24,663 |
Three Months Ended
|
||||||||||||||||
2008
|
March 31
|
June 30
|
September 30
|
December 31
|
||||||||||||
Total
revenue
|
$ | 2,601 | $ | 2,619 | $ | 1,580 | $ | 675 | ||||||||
Gross
profit *
|
536 | 626 | 406 | 190 | ||||||||||||
Net
loss attributable to common stockholders
|
(1,590 | ) | (2,143 | ) | (2,381 | ) | (3,259 | ) | ||||||||
Basic
and diluted net loss per common share
|
(0.20 | ) | (0.26 | ) | (0.29 | ) | (0.40 | ) |
Three Months Ended
|
||||||||||||||||
2007
|
March 31
|
June 30
|
September 30
|
December 31
|
||||||||||||
Total
revenue
|
$ | 216 | $ | 1,243 | $ | 2,460 | $ | 1,006 | ||||||||
Gross
profit *
|
100 | 1,138 | 2,293 | 268 | ||||||||||||
Net
(loss) income attributable to common stockholders
|
(1,815 | ) | (519 | ) | 651 | (2,852 | ) | |||||||||
Basic
and diluted net (loss) income per common share
|
(0.30 | ) | (0.08 | ) | 0.09 | (0.38 | ) |
Item 9.
|
Changes
in and Disagreements with Accountants on Accounting and Financial
Disclosure
|
Item 9A.
|
Controls
and Procedures
|
Item 9B.
|
Other
Information
|
Item 10.
|
Directors,
Executive Officers and Corporate
Governance
|
Item 11.
|
Executive
Compensation
|
Item 12.
|
Security
Ownership of Certain Beneficial Owners and Management and Related
Stockholder Matters
|
Item 13.
|
Certain
Relationships and Related Transactions, and Director
Independence
|
Item 14.
|
Principal
Accounting Fees and Services
|
Item 15.
|
Exhibits
and Financial Statement Schedules
|
(a)
|
(1) Financial
Statements
|
|
Consolidated
Statements of Changes in Stockholders’ Equity for the years ended December
31, 2008, 2007 and 2006
|
(b)
|
Exhibits
|
3(i)(a)
|
Restated
Certificate of Incorporation dated as of March 21, 2007 (incorporated by
reference to Exhibit 3(i)(a) to Annual Report on Form 10-K filed on March
20, 2007).
|
|
3(i)(b)
|
Certificate
of Amendment to Restated Certificate of Incorporation dated as of June 15,
2007 (incorporated by reference to Exhibit 3(i)(b) to Registration
Statement on Form S-1 [No. 333-144201] dated on June 29,
2007).
|
|
3(i)(c)
|
Certificate
of Elimination of Series A Convertible Preferred Stock dated June 18, 2004
(incorporated by reference to Exhibit to Registration Statement on Form
S-8 [No. 333-117057] dated July 1, 2004).
|
|
3(ii)
|
By-Laws
as amended through November 6, 2008 (incorporated by reference to Exhibit
3.1 to Quarterly Report on Form 10-Q filed on November 10,
2008).
|
|
4
|
Specimen
Stock Certificate, Common Stock (incorporated by reference to Exhibit to
Registration Statement on Form S-1 (No. 33-95840) dated as of August 16,
1995).
|
|
10(a)
|
Assignment
of Intellectual Property Rights by Fuel-Tech N.V. to Platinum Plus, Inc.
as of November 5, 1997 (incorporated by reference to Exhibit to Form 10-K
for the year ended December 31,
1997).
|
10(b)
|
Assignment
of Intellectual Property Rights by Fuel Tech, Inc. to Clean Diesel
Technologies, Inc. as of November 5, 1997 (incorporated by reference to
Exhibit to Form 10-K for the year ended December 31,
1997).
|
|
10(c)
|
Assignment
Agreement as of November 5, 1997 among Platinum Plus, Inc., Fuel-Tech N.V.
and Clean Diesel Technologies, Inc. (incorporated by reference to Exhibit
to Form 10-K for the year ended December 31, 1997).
|
|
10(d)
|
Incentive
Plan as amended through June 11, 2002 (incorporated by reference to
Exhibit 10(d) to Annual Report on Form 10-K filed on March 30,
2007).
|
|
10(e)
|
Form
of Incentive Stock Option Agreement (incorporated by reference to Exhibit
10(g) to Annual Report on Form 10-K filed on March 30,
2007).
|
|
10(f)
|
Form
of Non-Qualified Stock Option Agreement (incorporated by reference to
Exhibit 10(h) to Form 10-K filed on March 30, 2007).
|
|
10(g)
|
Form
of Non-Executive Director Stock Option Agreement (incorporated by
reference to Exhibit to Registration Statement on Form S-8 [No.
333-117057] dated July 1, 2004).
|
|
10(h)
|
Management
Services Agreement between Clean Diesel Technologies, Inc., Fuel Tech,
Inc. and Fuel-Tech N.V. as of June 1, 1996 (incorporated by reference to
Exhibit to Form 10-Q for the quarter ended September 30,
1996).
|
|
10(i)
|
Office
Lease dated as of January 29, 2004 (incorporated by reference to Exhibit
to Form 10-Q for quarter ended June 30, 2004).
|
|
10(j)
|
Registration
Rights Agreement between Clean Diesel Technologies, Inc. and Fuel-Tech
N.V. of November 5, 1997 (incorporated by reference to Exhibit to Form
10-K for the year ended December 31, 1997).
|
|
10(k)
|
Registration Rights Agreement
between Clean Diesel Technologies, Inc. and Fuel-Tech N.V. of March 24,
1997 (incorporated by reference to Exhibit to Form 10-K for the year ended
December 31, 1996).
|
|
10(l)
|
Registration
Rights Agreement between Clean Diesel Technologies, Inc. and the holders
of Series A Convertible Preferred Stock as of November 11, 1998
(incorporated as reference to Exhibit to Form 10-Q for the period ended
September 30, 1998).
|
|
10(m)
|
License
Agreement of July 13, 2001 between Clean Diesel Technologies, Inc. and
Mitsui Co., Ltd as amended by Amendment No. 1 of December
18, 2002 (incorporated as reference to Exhibit to Form 10-Q for
quarter ended June 30, 2004).
|
|
10(n)
|
License
Agreement of March 31, 2003 between Clean Diesel Technologies, Inc. and
Combustion Components Associates, Inc. (incorporated by reference to
Exhibit to Exhibit to Form 10-Q for quarter ended June 30,
2004).
|
|
10(o)
|
Employment
Agreement dated September 23, 2003 between Tim Rogers and the Company
(incorporated by reference to Exhibit10(x) to Annual Report on Form 10-K
filed on March 30, 2007).
|
|
10(p)
|
Employment
Agreement dated June 14, 2005 between Walter Copan and the Company
(incorporated by reference to Exhibit to Form 8-K dated as of August 3,
2005).
|
|
10(q)
|
Employment
Agreement dated November 29, 2006 between Ann B. Ruple and the Company
(incorporated by reference to Exhibit 10(z) to Annual Report on Form 10-K
filed on March 30,
2007).
|
10(r)
|
Employment
Agreement dated as of January 1, 2008 between Bernhard Steiner and the
Company.
|
|
Employment
Agreement dated August 21, 2008 and
Addendum thereto dated August 26, 2008 between Michael Asmussen and
the Company.
|
||
Office
lease dated as of September 2008.
|
||
14
|
Code
of Ethics and Business Conduct (incorporated by reference to Exhibit to
Annual Report on Form 10-K for the year ended December 31,
2004).
|
|
Subsidiaries.
|
||
Consent
of Eisner LLP.
|
||
Section
302 CEO Certification.
|
||
Section
302 CFO Certification.
|
||
Section
906 Certification by CEO and CFO.
|
||
- -
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
-
|
||
#
|
Filed
herewith.
|
(in
thousands)
|
Balance at Beginning of
Period
|
Additions
Charged to Costs and Expenses
|
Additions
Charged to Other Accounts
|
Deductions*
|
Balance at End of Period
|
|||||||||||||||
Year
Ended
|
||||||||||||||||||||
December
31, 2006
|
$ | 11 |
$
|
34 | $ | - | $ | 11 | $ | 34 | ||||||||||
December
31, 2007
|
$ | 34 |
$
|
28 | $ | - | $ | 13 | $ | 49 | ||||||||||
December
31, 2008
|
$ | 49 |
$
|
629 | $ | - | $ | 319 | $ | 359 | ||||||||||
* Uncollected
receivables written off, net of recoveries and translation
adjustment
|
CLEAN DIESEL TECHNOLOGIES, INC. | ||||
March 16, 2009
|
By:
|
/s/ Michael L.
Asmussen
|
||
Date
|
Michael
L. Asmussen
|
|||
Chief
Executive Officer, President and
Director
|
/s/ Michael L.
Asmussen
|
Chief
Executive Officer, President and Director
|
|
Michael
L. Asmussen
|
(principal
executive officer)
|
|
/s/ Ann B.
Ruple
|
Chief
Financial Officer, Vice President and Treasurer
|
|
Ann
B. Ruple
|
(principal
financial and accounting officer)
|
|
/s/ John A. de
Havilland
|
Director
|
|
John
A. de Havilland
|
||
/s/ Derek R.
Gray
|
Director,
Non-Executive Chairman of the Board of Directors
|
|
Derek
R. Gray
|
||
/s/ Charles W.
Grinnell
|
Director,
Vice President and Corporate Secretary
|
|
Charles
W. Grinnell
|
||
/s/ John J.
McCloy
|
Director
|
|
John
J. McCloy
|
||
/s/ David F.
Merrion
|
Director
|
|
David
F. Merrion
|
||
/s/ David
Gammon
|
Director
|
|
David
Gammon
|